Clinical Trial Update: Post Marketing Surveillance for PROSENSE™ a Cryotherapy Treatment of Renal Cell Carcinoma [NA]

View source ↗

Summary

This entry notes a post-marketing surveillance study of PROSENSE cryotherapy for renal cell carcinoma, with the study status ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• PROSENSE

Snippet

Sponsor: IceCure Medical Ltd. | Conditions: Renal Cell Carcinoma | NA | Status: ACTIVE_NOT_RECRUITING